Smith & Nephew plc (SNN) has a profit margin of 9.2%, below the Healthcare sector average of 21.34%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for SNN is 9.2% as of June 2026. That compares with 4.73% in the prior-year period — up 94.6% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside Smith & Nephew plc's historical trend and sector peers before judging valuation or financial health.
Over the past year, SNN's profit margin moved from 4.73% to 9.2% — a 94.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Smith & Nephew plc's valuation or profitability profile.
Against Healthcare companies, SNN currently prints 9.2% for profit margin, while the sector average sits near 21.34%. That is roughly 56.9% below the sector mean. Large gaps often invite a closer look at Smith & Nephew plc's growth, margins, and balance sheet.
Profit Margin shows how effectively Smith & Nephew plc converts resources into returns. At 9.2%, SNN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 4.73% in the prior-year period — up 94.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting SNN's profit margin (9.2%), review year-over-year change from 4.73%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.